Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xtl Biopharma ADR (XTLB)

Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xtl Biopharma ADR 26 BEN-GURION ST. RAMAT GAN L3 5112001 ISR

www.xtlbio.com Employees: 0 P: 972-3611-6600 F: 972-361-1660

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company developing drugs against hepatitis.

Key Statistics

Overview:

Market Capitalization, $K 7,139
Enterprise Value, $K 6,909
Shares Outstanding, K 8,814
Annual Sales, $ 450 K
Annual Net Income, $ -1,030 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -550 K
EBIT, $ -180 K
EBITDA, $ -1,970 K
60-Month Beta 1.18
% of Insider Shareholders 29.00%
% of Institutional Shareholders 4.40%
Float, K 6,258
% Float 71.00%
Short Interest 2
Short Float 0.03%
Short Volume Ratio 0.45

Growth:

1-Year Return -53.23%
3-Year Return -34.37%
5-Year Return -71.60%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 12/30/24
Next Earnings Date 12/29/25 [--]
Earnings Per Share ttm -0.16
EPS Growth vs. Prev Qtr 30.77%
EPS Growth vs. Prev Year -125.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/10/17

XTLB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -228.89%
Debt/Equity 0.03
Price/Sales 16.61
Price/Cash Flow N/A
Price/Book 1.38
Book Value/Share 0.62
Interest Coverage -9.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar